
InMode Ltd. Net Debt | INMD
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt InMode Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -294 M | -148 M | -135 M | -94 M | - | - | - | -34.8 M | -17.6 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -17.6 M | -294 M | -121 M |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Medical devices industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GBS
GBS
|
-2.17 M | - | -0.57 % | $ 7.12 M | ||
|
Second Sight Medical Products
EYES
|
2.62 M | - | -0.97 % | $ 54.4 M | ||
|
EDAP TMS S.A.
EDAP
|
-26.7 M | - | - | $ 162 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
38.7 M | - | - | $ 1.77 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
6.46 M | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
-32.4 M | - | 1.37 % | $ 20.5 M | ||
|
Allied Healthcare Products
AHPI
|
-3.31 M | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
252 K | - | 37.08 % | $ 85.7 M | ||
|
Cognyte Software Ltd.
CGNT
|
-110 M | $ 8.47 | 0.71 % | $ 618 M | ||
|
ClearPoint Neuro
CLPT
|
3.85 M | $ 13.96 | 0.67 % | $ 395 M | ||
|
Apollo Endosurgery
APEN
|
-22.5 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
-12.4 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-77.2 M | - | - | $ 3.31 B | ||
|
BIOLASE
BIOL
|
6.1 M | - | -13.19 % | $ 166 K | ||
|
Soliton, Inc.
SOLY
|
-31.6 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-9.02 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-2.3 M | - | 0.03 % | $ 1.58 B | ||
|
Conformis
CFMS
|
-26.2 M | - | - | $ 16.4 M | ||
|
Misonix, Inc.
MSON
|
5.72 M | - | - | $ 462 M | ||
|
Dynatronics Corporation
DYNT
|
1.8 M | - | 14.99 % | $ 929 K | ||
|
Cardiovascular Systems
CSII
|
-64.6 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-140 M | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
-97.8 M | - | - | $ 10.2 M | ||
|
Intersect ENT, Inc.
XENT
|
50.8 M | - | - | $ 955 M | ||
|
Invacare Corporation
IVC
|
299 M | - | - | $ 24.7 M | ||
|
Inogen
INGN
|
-86.3 M | $ 5.42 | 0.18 % | $ 144 M | ||
|
Integer Holdings Corporation
ITGR
|
1.18 B | $ 126.5 | 0.8 % | $ 4.39 B | ||
|
Neovasc
NVCN
|
-51 M | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
83.3 M | $ 22.41 | 1.17 % | $ 526 M | ||
|
Cytosorbents Corporation
CTSO
|
11 M | $ 0.35 | 0.03 % | $ 21.8 M | ||
|
SmileDirectClub
SDC
|
763 M | - | -53.45 % | $ 9.71 M | ||
|
Sientra
SIEN
|
31.1 M | - | -16.59 % | $ 10.3 M | ||
|
Silk Road Medical, Inc
SILK
|
57.1 M | - | - | $ 1.07 B | ||
|
NanoVibronix
NAOV
|
-4.11 M | - | - | $ 1.08 M | ||
|
Surgalign Holdings
SRGA
|
-5.5 M | - | -32.98 % | $ 1.68 M | ||
|
ShockWave Medical
SWAV
|
407 M | - | - | $ 12.3 B | ||
|
NuVasive
NUVA
|
-238 M | - | - | $ 2.07 B | ||
|
Natus Medical Incorporated
NTUS
|
-64.1 M | - | 1.94 % | $ 1.05 B | ||
|
Nevro Corp.
NVRO
|
93.4 M | - | - | $ 217 M | ||
|
LENSAR
LNSR
|
-10.2 M | $ 8.58 | 4.0 % | $ 103 M | ||
|
ThermoGenesis Holdings
THMO
|
-4.05 M | - | -25.84 % | $ 171 K | ||
|
Talis Biomedical Corporation
TLIS
|
-57.1 M | - | 3.55 % | $ 7.96 M | ||
|
Titan Medical
TMDI
|
-31 M | - | -26.32 % | $ 19.6 M | ||
|
LivaNova PLC
LIVN
|
-282 M | $ 81.92 | 0.89 % | $ 4.47 B | ||
|
Butterfly Network
BFLY
|
-130 M | $ 7.36 | 0.96 % | $ 1.82 B | ||
|
Vapotherm
VAPO
|
-4.39 M | - | 6.72 % | $ 34 M | ||
|
Acutus Medical
AFIB
|
12.5 M | - | -26.83 % | $ 2.62 M | ||
|
Globus Medical
GMED
|
-511 M | $ 78.29 | 0.27 % | $ 10.6 B |